Evidence map›Paper›PMID 20297903›Full record

ArticleTissue engineering. Part A2010

Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded.

Andrew P Price, Kristen A England, Amy M Matson, Bruce R Blazar, Angela Panoskaltsis-Mortari

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 149 papers.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02625246 phase1completednot on this mapstarted 2016, after this paper: background citation

A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis Bronchiectasis

TypeinterventionalSponsorMarilyn GlassbergRan2016 to 2019Enrolled6ConditionsBronchiectasisArmshMSCs
NCT03137199 phase1terminatednot on this mapstarted 2017, after this paper: background citation

A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Mild Asthma

TypeinterventionalSponsorMarilyn GlassbergRan2017 to 2020Enrolled3ConditionsAsthmaArmshMSCs
3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 342 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Engineering Dynamic 3D Models of Lung.Advances in experimental medicine and biology · 2023
    Article
  15. Article
  16. Review
  17. Mechanical characterization of native and sugar-modified decellularized kidneys.Journal of the mechanical behavior of biomedical materials · 2021
    Article
  18. Review
  19. Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrew P PriceBlood and Marrow Transplant Program, Division of Hematology-Oncology, Department of Pediatrics, University of Minnesota Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Kristen A England
Amy M Matson
Bruce R Blazar
Angela Panoskaltsis-Mortari
University of Minnesota · US

Funding

POST BONE MARROW TRANSPLANT LUNG INJURY PATHOPHYSIOLOGYR01HL055209 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI PANOSKALTSIS-MORTARI, ANGELA · 1995 to 2009
$3.7M
NHLBI NIH HHS R01 HL055209
6 · The paper itself

Abstract

We developed a decellularized murine lung matrix bioreactor system that could be used to evaluate the potential of stem cells to regenerate lung tissue. Lungs from 2-3-month-old C57BL/6 female mice were excised en bloc with the trachea and heart, and decellularized with sequential solutions of distilled water, detergents, NaCl, and porcine pancreatic DNase. The remaining matrix was cannulated and suspended in small airway growth medium, attached to a ventilator to simulate normal, murine breathing-induced stretch. After 7 days in an incubator, lung matrices were analyzed histologically. Scanning electron microscopy and histochemical staining demonstrated that the pulmonary matrix was intact and that the geographic placement of the proximal and distal airways, alveoli and vessels, and the basement membrane of these structures all remained intact. Decellularization was confirmed by the absence of nuclear 4',6-diamidino-2-phenylindole staining and negative polymerase chain reaction for genomic DNA. Collagen content was maintained at normal levels. Elastin, laminin, and glycosaminglycans were also present, although at lower levels compared to nondecellularized lungs. The decellularized lung matrix bioreactor was capable of supporting growth of fetal alveolar type II cells. Analysis of day 7 cryosections of fetal-cell-injected lung matrices showed pro-Sp-C, cytokeratin 18, and 4',6-diamidino-2-phenylindole-positive cells lining alveolar areas that appeared to be attached to the matrix. These data illustrate the potential of using decellularized lungs as a natural three-dimensional bioengineering matrix as well as provide a model for the study of lung regeneration from pulmonary stem cells.

Indexed as

Bioartificial OrgansBioreactorsStem Cell TransplantationAnimalsBiomedical EngineeringCell-Free SystemEquipment DesignEquipment Failure AnalysisExtracellular MatrixFemaleLungMiceMice, Inbred C57BLOrgan Culture TechniquesTissue Engineering

Identifiers

PMID20297903
PMCPMC2947435
OpenAlexW2130806934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.